All Roll Calls
Yes: 89 • No: 12
New MexicoSB 2192025 Regular SessionSenateWALLET
MEDICAL PSILOCYBIN ACT
Sponsored By: Jeff Steinborn (Democratic)
Signed by Governor
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
6 provisions identified: 5 benefits, 1 costs, 0 mixed.
Legal protections for authorized psilocybin participants
Permitted producers, clinicians, qualified patients, and people present during authorized use receive protection from arrest, prosecution, and program-related penalties. Authorized activity alone cannot justify detention, searches, seizures, or property forfeiture. Covered people on probation, parole, or government supervision also cannot be penalized for authorized participation. Possession and transport must stay within department supply limits, and treatment must occur in approved settings. Protections exclude unauthorized activity and driving under the influence; the act does not cover FDA-approved clinical trials.
New medical psilocybin treatment for patients
New Mexico's health department must implement a medical psilocybin program by December 31, 2027. Qualifying conditions include major treatment-resistant depression, PTSD, substance use disorders, end-of-life care, and other department-approved conditions. Patients need approval from a permitted clinician and treatment in an approved setting; the department sets training, treatment, and safety standards. FDA-approved psilocybin products are generally outside the act. The law authorizes their use in research supported by research-fund grants and treatment for qualified patients eligible for treatment-equity funding.
Treatment fund helps income-qualified psilocybin patients
The law creates a state fund to help pay for medical psilocybin treatment. Patients must qualify for the program and meet income rules set by the health department. The fund accepts appropriations, gifts, grants, and donations, and unused money stays in the fund. The Legislature must approve spending; the law sets no funding amount, patient benefit amount, or income limit.
Research grants support medical psilocybin studies
The law creates a state fund for grants studying any aspect of medical psilocybin use. State research universities and health care providers are eligible recipients. The fund accepts appropriations, gifts, grants, and donations, and unused money stays in the fund. The Legislature must approve spending, and the law sets no funding amount.
Tax deduction for medical psilocybin sellers
Sellers can deduct receipts from psilocybin products and medical care sold under the Medical Psilocybin Act. The deduction applies to New Mexico gross receipts and governmental gross receipts taxes. The law sets no savings amount and does not require sellers to lower patient prices.
False psilocybin participation claims bring penalties
Fraudulently claiming program participation to a law enforcement officer is a petty misdemeanor. The claim must be made to avoid arrest or prosecution for a psilocybin-related offense.
Sponsors & Cosponsors
Sponsor
Jeff Steinborn
Democratic • Senate
Cosponsors
Andrea Romero
Democratic • House
Catherine J. Cullen
Republican • House
Craig W. Brandt
Republican • Senate
Elizabeth "Liz" Stefanics
Democratic • Senate
Elizabeth "Liz" Thomson
Democratic • House
Martin Hickey
Democratic • Senate
Shannon D. Pinto
Democratic • Senate
Stefani Lord
Republican • House
Roll Call Votes
House vote • 3/18/2025
Final House Vote
Yes: 56 • No: 8
Senate vote • 3/12/2025
Final Senate Vote
Yes: 33 • No: 4
Actions Timeline
Signed by Governor - Chapter 73 - Apr. 7
4/7/2025SenatePassed in the House of Representatives - Y:56 N:8
3/18/2025HouseHHHC: Reported by committee with Do Pass recommendation
3/17/2025HouseSent to HHHC - Referrals: HHHC
3/13/2025SenatePassed in the Senate - Y:33 N:4
3/12/2025SenateSenate Floor Amendment
3/12/2025SenateSFC: Reported by committee with Do Pass recommendation
3/10/2025SenateSJC: Reported by committee with Do Not Pass but with a Do Pass recommendation on Committee Substitution
3/6/2025SenateSTBTC: Reported by committee with Do Pass recommendation with amendment(s)
2/12/2025SenateSent to STBTC - Referrals: STBTC/SJC/SFC
1/30/2025Senate
Bill Text
Final Version
4/8/2025
HHHC Committee Report 3/17/25
3/17/2025
Senate Floor Amendment 1 3/12/25
3/12/2025
SFC Committee Report 3/10/25
3/10/2025
SJC Committee Report 3/06/25
3/6/2025
SJC Committee Substitute 3/06/25
3/6/2025
STBTC Committee Report 2/12/25
2/12/2025
Introduced
1/30/2025